65 studies found for:    Open Studies | "Diabetic Nephropathies"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Diabetic Nephropathies"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Unknown  Mycophenolate Mofetil, Carnitine and PDE5 Inhibitor, Three Potential Treatments for Resistant Proteinuria Slowing Diabetic Nephropathy Deterioration
Conditions: Diabetic Nephropathy;   Chronic Kidney Disease
Intervention: Drug: Mycophenolate Mofetil (MMF) ,phosphodiesterase 5 inhibitors , CARNITINE
2 Recruiting Efficacy and Safety of MT-3995 in Patients With Diabetic Nephropathy
Condition: Diabetic Nephropathy
Interventions: Drug: MT-3995 Low;   Drug: MT-3995 Middle;   Drug: MT-3995 High;   Drug: Placebo
3 Unknown  Association Between Rosiglitazone Use and Clinical Course of Diabetic Nephropathy: Population-Based Study
Conditions: Diabetes;   Diabetic Nephropathy;   Renal Protection
Intervention: Drug: Rosiglitasone (retrospective observation)
4 Recruiting Evaluation of the Effects of Canagliflozin on Renal and Cardiovascular Outcomes in Participants With Diabetic Nephropathy
Conditions: Diabetes Mellitus, Type 2;   Diabetic Nephropathy
Interventions: Drug: Canagliflozin;   Drug: Placebo
5 Recruiting Proteomic Prediction and Renin Angiotensin Aldosterone System Inhibition Prevention Of Early Diabetic nephRopathy In TYpe 2 Diabetic Patients With Normoalbuminuria
Conditions: Diabetic Nephropathy;   Diabetic Retinopathy
Interventions: Drug: Spironolactone;   Drug: Placebo;   Drug: Standard care
6 Unknown  Ramipril and Clopidogrel in Oxidative Stress, Vascular Inflammation and Endothelial Dysfunction in Type 2 Diabetes and Diabetic Nephropathy
Conditions: Diabetes Type 2;   Diabetic Nephropathy;   Vascular Disease
Interventions: Drug: Ramipril;   Drug: Clopidogrel
7 Recruiting Pyridorin in Diabetic Nephropathy
Conditions: Diabetic Nephropathy;   Diabetic Kidney Disease
Interventions: Drug: Pyridorin;   Drug: Placebo
8 Recruiting Validation of Biomarkers of Diabetic Nephropathy in Type I Diabetic Children
Condition: Type 1 Diabetes Mellitus With Diabetic Nephropathy
Intervention: Other: Urinary sample collection
9 Unknown  Colchicine for Diabetic Nephropathy
Condition: Diabetic Nephropathy
Intervention: Drug: colchicine
10 Unknown  Aldosterone in Diabetic Nephropathy
Condition: Diabetic Nephropathy
Interventions: Drug: Spironolactone;   Drug: Placebo
11 Not yet recruiting Colchicine for Diabetic Nephropathy Trial
Condition: Diabetic Nephropathies
Interventions: Drug: Colchicine;   Drug: Placebo
12 Recruiting Study Of Diabetic Nephropathy With Atrasentan
Condition: Diabetic Nephropathy
Interventions: Drug: Atrasentan;   Drug: Placebo
13 Unknown  Beraprost Sodium and Arterial Stiffness in Patients With Type 2 Diabetic Nephropathy
Condition: Diabetic Nephropathy
Intervention: Drug: Beraprost sodium
14 Recruiting Repository of Novel Analytes Leading to Autoimmune, Inflammatory and Diabetic Nephropathies (RENAL AID)
Conditions: Kidney Diseases;   Kidney Failure, Chronic;   Diabetic Nephropathy;   Lupus Nephritis;   Glomerulonephritis, IGA
15 Unknown  Study for the Effectiveness of Intensive Therapy Aiming at a Remission of Diabetic Nephropathy
Conditions: Type 2 Diabetes Mellitus;   Diabetic Nephropathy
Interventions: Drug: ACE inhibitors,ARB, HMG-CoA reductase inhibitors, vitamins;   Behavioral: Compliance, antismoking, and nutrition instruction
16 Not yet recruiting Semi-structured Chinese Medicine Treatment as an Adjuvant Therapy to the Management of Diabetic Nephropathy
Condition: Diabetic Nephropathies
Interventions: Drug: Semi-individualised Chinese Medicine treatment;   Drug: Routine medical care (active comparator)
17 Not yet recruiting Efficacy and Safety of Weekly Subcutaneous MLN1202 in Improving Diabetic Nephropathy in Participants With Macroalbuminuria
Condition: Diabetic Nephropathy
Interventions: Drug: MLN1202 Placebo;   Drug: MLN1202
18 Unknown  Sympathetic Nervous System Inhibition for the Treatment of Diabetic Kidney Disease
Condition: Diabetic Nephropathies
Interventions: Drug: Moxonidine;   Drug: Placebo
19 Recruiting Clinical Trial Technology Development for the Validation of Surrogate Prognostic Markers in Patients With Diabetic Nephropathy
Condition: Diabetic Nephropathy
Interventions: Drug: Calcitriol;   Drug: Placebo
20 Recruiting Impact of Multidisciplinary Self-care Management of Diabetic Nephropathy on Quality of Life, Self-care Behavior, Glycemic Control, and Renal Function.
Condition: Diabetic Kidney Disease
Intervention: Behavioral: Self-care management program

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years